WIPO logo
Mobile | Deutsch | Español | Français | 日本語 | 한국어 | Português | Русский | 中文 | العربية |
PATENTSCOPE

Search International and National Patent Collections
World Intellectual Property Organization
Search
 
Browse
 
Translate
 
Options
 
News
 
Login
 
Help
 
Machine translation
1. (WO2005115462) COMBINATIONS COMPRISING ANTIMUSCARINIC AGENTS AND PDE4 INHIBITORS
Latest bibliographic data on file with the International Bureau   

Pub. No.:    WO/2005/115462    International Application No.:    PCT/EP2005/005836
Publication Date: 08.12.2005 International Filing Date: 31.05.2005
IPC:
A61K 45/00 (2006.01), A61K 31/439 (2006.01), A61K 31/167 (2006.01), A61K 31/137 (2006.01), A61P 11/00 (2006.01), A61P 11/06 (2006.01), A61P 11/08 (2006.01)
Applicants: ALMIRALL PRODESFARMA S.A. [ES/ES]; Ronda del General Mitre 151, E-08022 Barcelona (ES) (For All Designated States Except US).
GRAS ESCARDO, Jordi [ES/ES]; (ES) (For US Only).
LLENAS CALVO, Jesus [ES/ES]; (ES) (For US Only).
RYDER, Hamish [GB/ES]; (ES) (For US Only).
ORVIZ DIAZ, Pio [ES/ES]; (ES) (For US Only)
Inventors: GRAS ESCARDO, Jordi; (ES).
LLENAS CALVO, Jesus; (ES).
RYDER, Hamish; (ES).
ORVIZ DIAZ, Pio; (ES)
Agent: R C SRINIVASAN; J. A. Kemp & Co, 14 South Square, Gray's Inn, London WC1R 5JJ (GB)
Priority Data:
P200401312 31.05.2004 ES
Title (EN) COMBINATIONS COMPRISING ANTIMUSCARINIC AGENTS AND PDE4 INHIBITORS
(FR) COMBINAISONS COMPRENANT DES AGENTS ANTIMUSCARINIQUES ET DES INHIBITEURS DE PDE4
Abstract: front page image
(EN)A combination which comprises (a) a PDE4 inhibitor and (b) an antagonist of M3 muscarinic receptors which is 3(R)-(2-hydroxy-2,2-dithien-2-ylacetoxy)-1­(3-phenoxypropyl)-1-azoniabicyclo[2.2.2]octane, in the form of a salt having an anion X, which is a pharmaceutically acceptable anion of a mono or polyvalent acid.
(FR)Cette invention concerne une combinaison, qui comprend: (a) un inhibiteur de PDE4 et (b) un antagoniste de récepteurs muscariniques M3 constitué par 3(R)-(2-hydroxy-2,2-dithién-2-ylacétoxy)-1-(3-phénoxypropyl)-1-azoniabicyclo[2.2.2]octane, sous la forme d'un sel comportant un anion X, constitué par un anion pharmaceutiquement acceptable d'un acide monovalent ou polyvalent.
Designated States: AE, AG, AL, AM, AT, AU, AZ, BA, BB, BG, BR, BW, BY, BZ, CA, CH, CN, CO, CR, CU, CZ, DE, DK, DM, DZ, EC, EE, EG, ES, FI, GB, GD, GE, GH, GM, HR, HU, ID, IL, IN, IS, JP, KE, KG, KM, KP, KR, KZ, LC, LK, LR, LS, LT, LU, LV, MA, MD, MG, MK, MN, MW, MX, MZ, NA, NG, NI, NO, NZ, OM, PG, PH, PL, PT, RO, RU, SC, SD, SE, SG, SK, SL, SM, SY, TJ, TM, TN, TR, TT, TZ, UA, UG, US, UZ, VC, VN, YU, ZA, ZM, ZW.
African Regional Intellectual Property Organization (BW, GH, GM, KE, LS, MW, MZ, NA, SD, SL, SZ, TZ, UG, ZM, ZW)
Eurasian Patent Organization (AM, AZ, BY, KG, KZ, MD, RU, TJ, TM)
European Patent Office (AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HU, IE, IS, IT, LT, LU, MC, NL, PL, PT, RO, SE, SI, SK, TR)
African Intellectual Property Organization (BF, BJ, CF, CG, CI, CM, GA, GN, GQ, GW, ML, MR, NE, SN, TD, TG).
Publication Language: English (EN)
Filing Language: English (EN)